Business Description
Aequus Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA0076361033
Compare
Compare
Traded in other countries / regions
AQS.CanadaAEQ.GermanyAQSZF.USA IPO Date
2015-03-17Description
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | -4.53 | |||||
| Debt-to-Equity | -1.15 | |||||
| Debt-to-EBITDA | -2.92 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -56.15 | |||||
| Beneish M-Score | -9.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -58.5 | |||||
| 3-Year EBITDA Growth Rate | -88.2 | |||||
| 3-Year EPS without NRI Growth Rate | -26 | |||||
| 3-Year FCF Growth Rate | -23.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.79 | |||||
| 9-Day RSI | 50.35 | |||||
| 14-Day RSI | 52.5 | |||||
| 6-1 Month Momentum % | -57.14 | |||||
| 12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.09 | |||||
| Quick Ratio | 0.07 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 1089.34 | |||||
| Days Sales Outstanding | 133.11 | |||||
| Days Payable | 3137.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.8 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.25 | |||||
| Operating Margin % | -1750.43 | |||||
| Net Margin % | -1864.96 | |||||
| FCF Margin % | -1217.09 | |||||
| ROA % | -195.4 | |||||
| ROIC % | -40.89 | |||||
| ROC (Joel Greenblatt) % | -314.12 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10 | |||||
| EV-to-EBIT | -5.22 | |||||
| EV-to-EBITDA | -5.49 | |||||
| EV-to-Revenue | 117.2 | |||||
| EV-to-FCF | -5.27 | |||||
| Earnings Yield (Greenblatt) % | -19.16 | |||||
| FCF Yield % | -34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aequus Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.117 | ||
| EPS (TTM) (C$) | -0.015 | ||
| Beta | 0.1 | ||
| Volatility % | 116.56 | ||
| 14-Day RSI | 52.5 | ||
| 14-Day ATR (C$) | 0.003052 | ||
| 20-Day SMA (C$) | 0.01775 | ||
| 12-1 Month Momentum % | -50 | ||
| 52-Week Range (C$) | 0.01 - 0.06 | ||
| Shares Outstanding (Mil) | 132.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aequus Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aequus Pharmaceuticals Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aequus Pharmaceuticals Inc Frequently Asked Questions
What is Aequus Pharmaceuticals Inc(TSXV:AQS)'s stock price today?
The current price of TSXV:AQS is C$0.02. The 52 week high of TSXV:AQS is C$0.06 and 52 week low is C$0.01.
When is next earnings date of Aequus Pharmaceuticals Inc(TSXV:AQS)?
The next earnings date of Aequus Pharmaceuticals Inc(TSXV:AQS) is .
Does Aequus Pharmaceuticals Inc(TSXV:AQS) pay dividends? If so, how much?
Aequus Pharmaceuticals Inc(TSXV:AQS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers